These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3303693)

  • 1. [Treatment of stomach ulcer with the Bulgarian preparation Farmaxolon].
    Brailski Kh; Dimitrov B; Matov V; Damianov B
    Vutr Boles; 1987; 26(3):43-50. PubMed ID: 3303693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbenoxolone patients with gastric ulcers. A double-blind trial.
    Schwamberger K; Reissigl H
    Scand J Gastroenterol Suppl; 1980; 65():59-62. PubMed ID: 7010529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cimetidine-resistant gastric ulcer with carbenoxolone-sodium (author's transl)].
    Simon B; Kather H; Kommerell B
    Med Klin; 1979 Aug; 74(35):1250-3. PubMed ID: 492046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of gastric ulcer.
    LaBrooy SJ
    Ann Acad Med Singap; 1983 Oct; 12(4):548-54. PubMed ID: 6146287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial.
    Barbara L; Belsasso E; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Giorgi-Conciato M; Marletta F; Miglioli M; Petrillo M; Salvagnini M; Scalabrin G
    Scand J Gastroenterol Suppl; 1979; 57():21-4. PubMed ID: 396653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind study of carbenoxolone in gastric ulcer and erosions.
    Lehtola J; Karvonen AL; Tunturi-Hihnala H
    Ann Clin Res; 1978 Feb; 10(1):19-23. PubMed ID: 354471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of peptic ulcer in the stomach and duodenum using carbenoxolone (Biogastrone and Biogastrone-Duodenal)].
    Ronský R; Fric P; Huslarová A; Malis F; Josífko M
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):98-104. PubMed ID: 350435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer].
    Stadnicki A
    Pol Tyg Lek; 1979 Jun; 34(26):1029-31. PubMed ID: 503921
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastric epithelial cell turnover, mucus production, and healing of gastric ulcers with carbenoxolone.
    Domschke W; Domschke S; Hagel J; Demling L; Croft DN
    Gut; 1977 Oct; 18(10):817-20. PubMed ID: 590840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastric emptying in dyspeptic syndromes during treatment with a combination of carbenoxolone and metoclopramide, studied with a meal labeled with 99mTc colloidal sulfate].
    Sciarretta G; Turba E; Verri A; Pinetti P; Malaguti P
    Clin Ter; 1980 Jun; 93(6):639-48. PubMed ID: 7428319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined cimetidine and carbenoxolone sodium for gastric ulcer].
    Niv Y; Bat L; Shemesh E
    Harefuah; 1982; 103(12):347-8. PubMed ID: 7183486
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbenoxolone and gastric Technetium-99m pertechnetate uptake in patients with gastric ulceration.
    Williams JG; Croft DN
    Scand J Gastroenterol Suppl; 1980; 65():29-33. PubMed ID: 6259714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.